Uses of C-type sodium diuretic peptide variants for the treatment of bone dysplasia

摘要

The present invention provides C-type sodium diuretic peptides (e. G.) For treating bone dysplasia, one or more symptoms of bone dysplasia, such as iliac growth or growth rate, and other diseases with bone dysplasia and / or CNP- CNP), and CNP variant peptides, as well as the use of the novel pharmaceutical compositions and formulations.